Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-05-04
DOI
10.1007/s40257-023-00774-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Therapeutics in the Management of Connective Tissue Disease. Part I. Lupus Erythematosus and Sjögren’s Syndrome
- (2022) Lauren Skudalski et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
- (2022) Steven R. Ytterberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
- (2022) Eric F Morand et al. Lancet Rheumatology
- Prevalence and factors associated with long-term remission in cutaneous lupus: A longitudinal cohort study of 141 cases
- (2022) Damien Fayard et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Acitretin treatment in antimalarial-refractory/intolerant discoid lupus erythematosus: A prospective, open-label, uncontrolled study
- (2022) Kulwadee Laosakul et al. LUPUS
- Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus
- (2022) Joan T. Merrill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab
- (2022) Jack Arnold et al. RHEUMATOLOGY
- Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation
- (2022) Allison C. Billi et al. Science Translational Medicine
- Multidimensional immune profiling of cutaneous lupus erythematosus in vivo stratified by patient responses to antimalarials
- (2022) Jay Patel et al. Arthritis & Rheumatology
- The Genetic Landscape of Cutaneous Lupus Erythematosus
- (2022) Henry W. Chen et al. Frontiers in Medicine
- Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus
- (2022) Tanja Fetter et al. Frontiers in Medicine
- B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus
- (2022) Nikhil Mehta et al. BMJ Case Reports
- POS0190 EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES
- (2022) E. F. Morand et al. ANNALS OF THE RHEUMATIC DISEASES
- LB0004 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYK2 INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
- (2022) E. Morand et al. ANNALS OF THE RHEUMATIC DISEASES
- AB0432 EFAVALEUKIN ALFA, A NOVEL IL-2 MUTEIN, SELECTIVELY EXPANDS REGULATORY T CELLS IN PATIENTS WITH SLE: FINAL RESULTS OF A PHASE 1B MULTIPLE ASCENDING DOSE STUDY
- (2022) N. Tchao et al. ANNALS OF THE RHEUMATIC DISEASES
- Anifrolumab for Treatment of Refractory Cutaneous Lupus Erythematosus
- (2022) Franklin R. Blum et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
- (2022) Victoria P. Werth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus–Like Inflammation
- (2022) Nazgol-Sadat Haddadi et al. Frontiers in Immunology
- Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach
- (2022) Marlene Plüß et al. Journal of Clinical Medicine
- Influence of Socio-Demographic Factors in Patients With Cutaneous Lupus Erythematosus
- (2022) Amanda M. Walker et al. Frontiers in Medicine
- Emerging Therapies in Cutaneous Lupus Erythematosus
- (2022) Grant Sprow et al. Frontiers in Medicine
- Subacute cutaneous lupus erythematosus successfully treated with topical delgocitinib
- (2022) Ayano Maruyama et al. JOURNAL OF DERMATOLOGY
- A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
- (2022) Kenneth C. Kalunian et al. Arthritis & Rheumatology
- Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns
- (2022) Luka de Vos et al. Frontiers in Medicine
- Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency
- (2021) Emma J. Keller et al. Frontiers in Immunology
- Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis—Translation of Pathogenic Fundamentals Into an In Vitro Model
- (2021) Christine Braegelmann et al. Frontiers in Immunology
- Successful treatment of two cases of refractory cutaneous lupus erythematosus with belimumab
- (2021) Xavier Bosch-Amate et al. Indian Journal of Dermatology Venereology & Leprology
- Phase 2, Randomized, Placebo-Controlled Trial of Dapirolizumab Pegol in Patients with Moderate-to-Severe Active Systemic Lupus Erythematosus
- (2021) Richard A Furie et al. RHEUMATOLOGY
- Human cutaneous B cells: what do we really know?
- (2021) Irina Lerman et al. Annals of Translational Medicine
- B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus
- (2021) Scott A Jenks et al. ANNALS OF THE RHEUMATIC DISEASES
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus (CLE) 2021
- (2021) D. O’Kane et al. BRITISH JOURNAL OF DERMATOLOGY
- S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics
- (2021) Margitta Worm et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores
- (2021) Margitta Worm et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells
- (2021) Suqing Zhou et al. JOURNAL OF AUTOIMMUNITY
- Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: a cohort study
- (2021) Emily Keyes et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Belimumab in subacute cutaneous lupus erythematosus
- (2021) Vicenç Torrente-Segarra et al. LUPUS
- Filgotinib or Lanraplenib in Moderate to Severe Cutaneous Lupus Erythematosus: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study
- (2021) Victoria P Werth et al. RHEUMATOLOGY
- Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
- (2021) Jodi L. Karnell et al. Science Translational Medicine
- Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
- (2021) Dennis Niebel et al. Vaccines
- Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib
- (2021) L. Joos et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia
- (2021) Alexander Kreuter et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus
- (2021) A. Calugareanu et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2
- (2021) Binbin Yang et al. Frontiers in Immunology
- B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity
- (2021) Lisa Abernathy-Close et al. Frontiers in Immunology
- Targeted Therapies in Autoimmune Skin Diseases
- (2021) Christine Braegelmann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of cutaneous lupus erythematosus
- (2020) Hong Shi et al. CURRENT OPINION IN RHEUMATOLOGY
- Lupus érythémateux cutanés réfractaires traités par bélimumab : étude descriptive monocentrique
- (2020) F. Dresco et al. REVUE DE MEDECINE INTERNE
- Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions
- (2020) Tanja Fetter et al. Frontiers in Immunology
- Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients
- (2020) Yongjian Chen et al. AUTOIMMUNITY
- Cutaneous Lupus Erythematosus: Progress and Challenges
- (2020) Amy J. Petty et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Belimumab for refractory manifestations of cutaneous lupus: a multicenter, retrospective observational study of 16 patients
- (2020) Romain Salle et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An Update on the Pathogenesis of Skin Damage in Lupus
- (2020) Qianwen Li et al. Current Rheumatology Reports
- Cutaneous lupus erythematosus: The impact of self‐amplifying innate and adaptive immune responses and future prospects of targeted therapies
- (2020) Tanja Fetter et al. EXPERIMENTAL DERMATOLOGY
- NEW INSIGHTS INTO THE PROGRESSION FROM CUTANEOUS LUPUS TO SYSTEMIC LUPUS ERYTHEMATOSUS
- (2020) Wenhui Zhou et al. Expert Review of Clinical Immunology
- Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases
- (2020) Valerie Reymann et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
- (2020) Colton J. Garelli et al. Frontiers in Immunology
- Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
- (2020) Leanna M. Wise et al. Frontiers in Medicine
- Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
- (2020) Lennard Ostendorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice
- (2020) Jay Patel et al. Current Rheumatology Reports
- Comparison of effectiveness of topical tacrolimus 0.1% vs topical halobetasol propionate 0.05% as an add‐on to oral hydroxychloroquine in discoid lupus erythematosus
- (2020) Deva Pratim Barua et al. Dermatologic Therapy
- Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study
- (2020) Alex Walker et al. EXPERIMENTAL DERMATOLOGY
- Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches
- (2020) Tanja Fetter et al. Cells
- Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients
- (2020) Raphael Aitmehdi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
- (2019) Richard Furie et al. JOURNAL OF CLINICAL INVESTIGATION
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Investigating the presence of neutrophil extracellular traps in cutaneous lesions of different subtypes of lupus erythematosus
- (2019) Rémi Safi et al. EXPERIMENTAL DERMATOLOGY
- Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies
- (2019) Joerg Wenzel Nature Reviews Rheumatology
- The contribution of macrophages to systemic lupus erythematosus
- (2019) Chunyan Ma et al. CLINICAL IMMUNOLOGY
- Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus
- (2019) Pragnesh Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Niche for Plasma Cells: The Skin
- (2019) Selda Karaaslan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- (2018) Siriorn Udompanich et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- TLR4+CXCR4+plasma cells drive nephritis development in systemic lupus erythematosus
- (2018) Kongyang Ma et al. ANNALS OF THE RHEUMATIC DISEASES
- Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa
- (2018) Mrinal K Sarkar et al. ANNALS OF THE RHEUMATIC DISEASES
- Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients
- (2018) Mei Liu et al. Cellular & Molecular Immunology
- Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors
- (2018) Tobias Alexander et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Analysis of possible structures of inducible skin-associated lymphoid tissue in lupus erythematosus profundus
- (2018) Toshiaki Kogame et al. JOURNAL OF DERMATOLOGY
- Natural History of Disease Activity and Damage in Patients with Cutaneous Lupus Erythematosus
- (2018) Khor Jia Ker et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus
- (2018) Teri M. Greiling et al. Science Translational Medicine
- IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
- (2018) Shu Wang et al. Nature Communications
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
- (2018) Susan Malkiel et al. Frontiers in Immunology
- Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus
- (2018) Adam C. Labonte et al. PLoS One
- Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
- (2018) Rita Quelhas da Costa et al. JAMA Dermatology
- High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus
- (2017) Joerg Wenzel et al. EXPERIMENTAL DERMATOLOGY
- IL-21 May Promote Granzyme B-Dependent NK/Plasmacytoid Dendritic Cell Functional Interaction in Cutaneous Lupus Erythematosus
- (2017) Valentina Salvi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immunostimulatory Endogenous Nucleic Acids Drive the Lesional Inflammation in Cutaneous Lupus Erythematosus
- (2017) Benedikt Scholtissek et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone
- (2017) S Mohammadi et al. LUPUS
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- (2017) Caroline Gordon et al. RHEUMATOLOGY
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus
- (2017) Yale Liu et al. Frontiers in Immunology
- Cutaneous lupus erythematosus
- (2016) Jasmine N. Stannard et al. CURRENT OPINION IN RHEUMATOLOGY
- Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients
- (2016) Christine Braegelmann et al. EXPERIMENTAL DERMATOLOGY
- Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus
- (2016) N. Patsinakidis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
- (2016) A. Kuhn et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Belimumab for the treatment of recalcitrant cutaneous lupus
- (2016) P Vashisht et al. LUPUS
- Advances in the treatment of cutaneous lupus erythematosus
- (2016) A Kuhn et al. LUPUS
- Monogenic Lupus
- (2016) Mindy S. Lo Current Rheumatology Reports
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus
- (2015) Feng Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus
- (2015) T. Gambichler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Lupus erythematosus revisited
- (2015) Annegret Kuhn et al. Seminars in Immunopathology
- Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus
- (2015) Edward M. Vital et al. Arthritis & Rheumatology
- Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database
- (2014) A. Kuhn et al. BRITISH JOURNAL OF DERMATOLOGY
- Photosensitivity, Apoptosis, and Cytokines in the Pathogenesis of Lupus Erythematosus: a Critical Review
- (2014) Annegret Kuhn et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
- (2014) J. C. Crispin et al. JOURNAL OF IMMUNOLOGY
- Type I Interferon in the Pathogenesis of Lupus
- (2014) M. K. Crow JOURNAL OF IMMUNOLOGY
- T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus
- (2014) Xue Yang et al. PLoS One
- The Pathology of T Cells in Systemic Lupus Erythematosus
- (2014) Anselm Mak et al. Journal of Immunology Research
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- Cutaneous lupus erythematosus: Diagnosis and treatment
- (2013) L.G. Okon et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation
- (2013) J. J. Karrich et al. BLOOD
- Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus
- (2013) Nien Yee Kow et al. Clinical & Developmental Immunology
- NK cells dysfunction in systemic lupus erythematosus: relation to disease activity
- (2013) Ana Henriques et al. CLINICAL RHEUMATOLOGY
- Aberrant B Cell Selection and Activation in Systemic Lupus Erythematosus
- (2013) Laurens P. Kil et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus
- (2013) Silke C. Hofmann et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Differential expression of BAFF and its receptors in discoid lupus erythematosus patients
- (2013) Benjamin F. Chong et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Role of type I interferons in the activation of autoreactive B cells
- (2012) Kerstin Kiefer et al. IMMUNOLOGY AND CELL BIOLOGY
- c-Jun and Ets2 Proteins Regulate Expression of Spleen Tyrosine Kinase in T Cells
- (2012) Debjani Ghosh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden
- (2011) C.M. Grönhagen et al. BRITISH JOURNAL OF DERMATOLOGY
- Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretion
- (2011) Verena Kopfnagel et al. EXPERIMENTAL DERMATOLOGY
- Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus
- (2011) Alexander Kreuter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- LL-37 expression in the skin in systemic lupus erythematosus
- (2011) C-L Sun et al. LUPUS
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
- (2011) R. Lande et al. Science Translational Medicine
- Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus
- (2010) Yi Li et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- IL-17 in Systemic Lupus Erythematosus
- (2010) José C. Crispín et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9
- (2010) Cristiana Guiducci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
- (2010) A. Chang et al. JOURNAL OF IMMUNOLOGY
- Evidence for a Pathophysiological Role of Keratinocyte-Derived Type III Interferon (IFNλ) in Cutaneous Lupus Erythematosus
- (2010) Sabine Zahn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
- (2010) A. Hakkim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis
- (2009) M. Grassi et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage
- (2009) William Vermi et al. IMMUNOBIOLOGY
- DNA demethylation of the perforin promoter in CD4+ T cells from patients with subacute cutaneous lupus erythematosus
- (2009) Yongqi Luo et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity
- (2009) Ayako Hayashi et al. Modern Rheumatology
- Neutrophilic Cutaneous Lupus Erythematosus
- (2008) Dan Lipsker et al. DERMATOLOGY
- Increased proportion of CD56brightnatural killer cells in active and inactive systemic lupus erythematosus
- (2008) Danika Schepis et al. IMMUNOLOGY
- Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis
- (2008) Oliver M. Steinmetz et al. KIDNEY INTERNATIONAL
- Narrow-band UVB-induced Externalization of Selected Nuclear Antigens in Keratinocytes: Implications for Lupus Erythematosus Pathogenesis
- (2008) Adam Reich et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started